Rilonacept

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 276 publications

Pathway for the Diagnosis and Management of Pericardial Disease: Contemporary Perspective.

Pathway for the Diagnosis and Management of Pericardial Disease: Contemporary Perspective.

Journal: Critical pathways in cardiology

Published: June 22, 2026

Retraction Note: Real-world data and Mendelian randomization analysis in assessing adverse reactions of rilonacept.

Retraction Note: Real-world data and Mendelian randomization analysis in assessing adverse reactions of rilonacept.

Journal: International journal of clinical pharmacy

Published: May 13, 2026

Interleukin-1: from discovery to therapeutic targeting of the first cytokine.

Interleukin-1: from discovery to therapeutic targeting of the first cytokine.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: March 02, 2026

Updates on Pathophysiology of Pericarditis to Guide Development of Therapeutics.

Updates on Pathophysiology of Pericarditis to Guide Development of Therapeutics.

Journal: Current cardiology reports

Published: February 10, 2026

Targeting cytokine pathways: the role of biologics in autoinflammatory disorders.

Targeting cytokine pathways: the role of biologics in autoinflammatory disorders.

Journal: Expert review of clinical immunology

Published: February 01, 2026

Comment on "Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX".

Comment on "Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX".

Journal: American journal of therapeutics

Published: January 29, 2026

Interleukin-1 Blockade With Rilonacept in Recurrent Pericarditis: Tapering and Discontinuation in Real-World Practice.

Interleukin-1 Blockade With Rilonacept in Recurrent Pericarditis: Tapering and Discontinuation in Real-World Practice.

Journal: JACC. Advances

Published: January 13, 2026

Biological Therapies for Urate Lowering and Inflammation Control in Gout Management.

Biological Therapies for Urate Lowering and Inflammation Control in Gout Management.

Journal: Journal of inflammation research

Published: December 31, 2025

Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS).

Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS).

Journal: Journal of cardiac failure

Published: December 12, 2025

Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis.

Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis.

Journal: Methodist DeBakey cardiovascular journal

Published: December 12, 2025

Recurrent Pericarditis Evolving to Constrictive Pericarditis and Pericardiectomy Over 18 Years.

Recurrent Pericarditis Evolving to Constrictive Pericarditis and Pericardiectomy Over 18 Years.

Journal: JACC. Case reports

Published: December 03, 2025

Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies.

Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies.

Journal: Autoimmunity reviews

Published: November 29, 2025

Showing 1-12 of 276

Last Updated: 06/30/2026